To receive email alerts whenever new press releases are issued or information is posted to this site, please send a message to the address below:

Interested institutional investors should contact:

Will Lewis
Chief Financial Officer, VP Administration
Aegerion Pharmaceuticals, Inc.
CenterPointe IV,
1140 Route 22 East, Suite 304,
Bridgewater, New Jersey 08807